Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer [NA]
Clinical trial update reporting cerebrospinal fluid levels of erlotinib in patients with stage III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Iressa Versus Docetaxel (Taxotere) [Phase 3]
Phase 3 trial comparing gefitinib (Iressa) with docetaxel (Taxotere) for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of Iressa (gefitinib) in patients with poor performance status and previously untreated advanced non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase II trial evaluating weekly paclitaxel (BMS-181339) in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 [Phase 2]
Phase 2 trial comparing erlotinib to standard chemotherapy in patients with advanced non-small cell lung cancer and ECOG performance status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem [Phase 2]
Phase 2 trial evaluating pemetrexed in combination with oxaliplatin for recurrent non-small cell lung cancer after platinum-based adjuvant f…
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating the safety and preliminary efficacy of ixabepilone in combination with carboplatin in patients with non-small cell …
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
This completed clinical trial updates hormone changes observed in women with Stage IIIB or Stage IV non-small cell lung cancer treated with …
-
CLINICAL_TRIALS trial_result · 2011-04-05Clinical Trial Update: Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer [Phase 1]
A Phase 1 safety trial evaluating bevacizumab (Avastin) with thoracic radiation in non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2011-04-04Clinical Trial Update: Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial update comparing Vinorelbine/Gemcitabine versus Vinorelbine/Carboplatin in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Performance Status During Treatment With Pemetrexed in Patients With NSCLC
This update summarizes performance status outcomes observed during pemetrexed treatment in patients with non-small cell lung cancer. The stu…
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer [Phase 2]
This document reports a completed Phase 2 clinical trial evaluating bavituximab in combination with paclitaxel and carboplatin for non-small…
-
CLINICAL_TRIALS trial_result · 2011-03-22Clinical Trial Update: Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase II trial evaluating concurrent docetaxel and carboplatin with radiotherapy and consolidation for locally advanced, inoperable non-smal…
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery [Phase 2]
Phase 2 trial evaluating genetic changes in non-small cell lung cancer patients treated with vinorelbine and gemcitabine before surgery.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer [Phase 3]
A Phase III randomized trial comparing surgery alone to surgery plus preoperative gemcitabine-cisplatin in early-stage non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 study evaluating the safety and feasibility of photodynamic therapy with HPPH in patients with non-small cell lung cancer. The trial…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer [Phase 1]
This update reports the completion of a Phase 1 trial evaluating a vaccine therapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for SB Injection in advanced and metastatic Non-Small Cell Lung Cancer. Current status of the trial is unknown…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801) [Phase 2]
A Phase 2 clinical trial evaluating pemetrexed plus carboplatin with radiation therapy for patients with inoperable locally advanced non-sma…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating SU011248 for safety and effectiveness in patients with non-small cell lung cancer and brain metastases has…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
This document reports an update on a Phase 2 trial evaluating first-line combination chemotherapy for unresectable stage IIIB or stage IV no…
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 MADe IT trial used molecular analyses to direct individualized therapy for advanced non-small cell lung cancer; results were posted …
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features [Phase 2]
Phase 2 trial of Velcade (bortezomib) in previously treated stage IIIB/IV bronchioloalveolar carcinoma and BAC-featured adenocarcinoma of th…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study of Tarceva (erlotinib) in patients with relapsed or refractory metastatic non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC [Phase 2]
Phase 2 study evaluating erlotinib (Tarceva) as a single agent or intercalated with chemotherapy in EGFR-positive non-small cell lung cancer…